The SDNA device is driving a new era of healthcare that turns to salivary collection and preservation as a means to detect viral infections and resolve the most common points of failure associated with whole saliva.
The device is heralded for its ability to maximize detection at the lowest levels and neutralize viruses within 10-seconds of collection to mitigate unnecessary viral exposure.
The company's patented preservation media keeps analytes stable for many weeks at ambient temperatures, ensuring safe, easy, and secure specimen storage and transport.
To ensure the highest degree of stringency and quality, automated methods for extraction and validation were performed on industry-leading platforms.
Near the beginning of the pandemic, Spectrum's SDNA-1000 was the first to gain FDA Emergency Use Authorization and introduce a nation, held under viral siege, to the noninvasive, highly accurate, and earliest detection benefits of COVID-19 testing using the self-collection of saliva.
With over two years of processing SARS-CoV-2 saliva tests, the device and its patented nucleic acid preservation chemistry have not only demonstrated but proven their unique and superior capabilities deserving of this new device clearance.
Headquartered in Salt Lake City, Utah, Spectrum Solutions is a healthcare solutions partner striving to bridge the gap between the science and real medical solutions.
Our laboratory products and services, clinical testing, and onsite compounding pharmacy are driving decentralized testing, accelerating multi-omic scientific applications, modernizing direct-to-consumer wellness, and delivering innovation with the practical power to impact and change outcomes.
L&T Technology Services plans to revolutionise medical imaging in collaboration with NVIDIA
Eli Lilly to build new high-tech manufacturing site in Germany
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Zymo Research's SafeCollect Saliva Collection Kit receives US FDA approval
Kanabo Group extends contract with major UK retailer
Biodesix enhances Nodify Lung testing with Tasso+ blood draw method
Byotrol unveils PROCESSUS instrument decontamination system
Integrum plans FDA PMA submission for OPRA in transhumeral amputations
Telix and Mauna Kea Technologies expand collaboration in urologic oncology surgery
Egetis secures exclusive licence agreement with Fujimoto for Emcitate development in Japan
KDx Diagnostics enters into strategic collaborations with leading distributors in Europe
Aplos Medical claims major GERD treatment milestone
Creo Medical receives US FDA clearance for Speedboat UltraSlim endoscopy device